{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-003868","form_type":"8-K","ticker":"CMPX","cik":"0001738021","company_name":"Compass Therapeutics, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.523972+00:00","generated_at":"2026-05-19T10:52:56.191669+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Compass Therapeutics annual meeting elects three directors, ratifies auditor","bullets":["Carl L. Gordon, Philip J. Ferneau, and James P. Boylan elected as Class II directors with 80.7M, 58.3M, and 83.6M votes for, respectively.","Ratification of CohnReznick LLP as auditor for FY2025 approved with 114.3M for, 28,647 against, 22,788 abstain.","Broker non-votes of 29,432,541 on director election."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-003868","json":"https://secwatch.observer/filing/0001171843-25-003868.json","markdown":"https://secwatch.observer/filing/0001171843-25-003868.md","text":"https://secwatch.observer/filing/0001171843-25-003868.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1738021/000117184325003868/0001171843-25-003868-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1738021/000117184325003868/f8k_061225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:52:56.191669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}